| Neurological Disease Mechanisms and Treatments | Lifetime | 5 | GB 1 | 99.93 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 5 | GB 2 | 99.83 |
| Dementia and Cognitive Impairment Research | Lifetime | 19 | GB 3 | 99.93 |
| Ginkgo biloba and Cashew Applications | Lifetime | 5 | GB 3 | 99.57 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 47 | GB 8 | 99.73 |
| Alzheimer's disease research and treatments | Lifetime | 64 | GB 7 | 99.80 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 84 | GB 16 | 99.66 |
| Functional Brain Connectivity Studies | Lifetime | 142 | GB 23 | 99.62 |
| Cerebrovascular and genetic disorders | Lifetime | 13 | GB 4 | 99.06 |
| Tryptophan and brain disorders | Lifetime | 162 | GB 17 | 99.00 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 339 | GB 22 | 99.01 |
| Neurological and metabolic disorders | Lifetime | 99 | GB 9 | 97.57 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 560 | GB 35 | 98.20 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 417 | GB 45 | 98.21 |
| Stress Responses and Cortisol | Lifetime | 520 | GB 38 | 98.12 |
| Advanced MRI Techniques and Applications | Lifetime | 879 | GB 100 | 98.08 |
| Acute Ischemic Stroke Management | Lifetime | 811 | GB 62 | 97.86 |
| French Literature and Criticism | Lifetime | 67 | GB 17 | 93.83 |
| Renaissance Literature and Culture | Lifetime | 152 | GB 33 | 92.68 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 851 | GB 54 | 94.62 |
| Hallucinations in medical conditions | Lifetime | 38 | GB 16 | 92.57 |
| Restless Legs Syndrome Research | Lifetime | 939 | GB 43 | 80.27 |
| Spatial Neglect and Hemispheric Dysfunction | Lifetime | 993 | GB 128 | 79.64 |
| Cognitive Functions and Memory | Lifetime | 796 | GB 64 | 76.60 |
| Drug-Induced Ocular Toxicity | Lifetime | 852 | GB 71 | 66.69 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 61 | GB 5 | 99.37 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 18 | GB 3 | 97.72 |
| Alzheimer's disease research and treatments | 2021-2025 | 98 | GB 7 | 98.90 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 149 | GB 13 | 97.83 |
| Advanced Neuroimaging Techniques and Applications | 2021-2025 | 186 | GB 16 | 96.05 |
| Functional Brain Connectivity Studies | 2021-2025 | 416 | GB 35 | 96.28 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 760 | GB 35 | 90.31 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 364 | GB 34 | 89.49 |
| Ginkgo biloba and Cashew Applications | 2021-2025 | 76 | GB 3 | 82.89 |
| Cerebrovascular and genetic disorders | 2021-2025 | 234 | GB 29 | 66.79 |
| Biotin and Related Studies | 2021-2025 | 331 | GB 8 | 44.05 |
| Cognitive Functions and Memory | 2021-2025 | 773 | GB 38 | 30.46 |
